)
Peptonic Medical (PMED) investor relations material
Peptonic Medical Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved a significant turnaround post-restructuring, with a more focused and cost-efficient organization positioned for sustainable growth and improved profitability.
Strategic focus on expanding the product portfolio in women's intimate health, with two new product launches under the VagiVital brand.
Strong development in the Norwegian consumer market, now a significant part of e-commerce sales.
Financial highlights
Net sales for Q1 2026 were 3,138 KSEK, down 17% year-over-year from 3,758 KSEK.
Gross profit was 2,121 KSEK (2,165 KSEK last year), with a gross margin of 68% (up from 58%).
Operating loss improved to -5,330 KSEK from -7,459 KSEK year-over-year.
Earnings per share were -0.0005 SEK, compared to -0.001 SEK in Q1 2025.
Cash flow from operations was -5,484 KSEK, with cash and bank balances at 628 KSEK as of March 31, 2026.
Outlook and guidance
Focus remains on product innovation, sales growth, and brand building in the women's health segment.
Anticipates capital inflow from upcoming warrants in June, which would further strengthen the financial position and support growth investments.
- Restructuring and cost control drove profitability gains amid lower sales and international expansion.PMED
Q4 202527 Feb 2026 - Restructuring led to lower sales but improved cost efficiency; new US/UK deal boosts outlook.PMED
Q3 20256 Nov 2025 - Cost cuts and margin gains halved losses, with break-even targeted for November 2025.PMED
Q2 202514 Aug 2025 - Revenue declined but gross margin and Nordic sales improved as US direct launch began.PMED
Q3 202413 Jun 2025 - Nordic sales surged 60% while group revenue fell; liquidity boosted by post-period rights issue.PMED
Q2 202413 Jun 2025 - Restructuring and new launches drive Peptonic's Q1, with improved margins despite lower sales.PMED
Q1 20256 Jun 2025 - Nordic sales up 76% and US launch underway, with improved margins and new financing secured.PMED
Q4 20246 Jun 2025
Next Peptonic Medical earnings date
Next Peptonic Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage